The two are not linked together. They had a previo

The two are not linked together. They had a previous PR that mentioned they sent the Top Line CD10 report to MHRA and other countries for emergency consideration. This BLA-type Fast Track meeting would be in follow up to that. Separately, it's also very encouraging that the UK is suggesting funding support for the CD12 getting started over there. Seems to indicate their interest in the drug in general, which bodes well for possible approval in that population. But NP was careful to caveat -- it's just a meeting -- they could easily decide the risk/reward is unwarranted for Mild-Moderates... and wait for interim severe data so close around the corner, before deciding... These are great new developments!